Basal Cell Carcinoma After High Dose Rate Brachytherapy: Medium-term Dermoscopic Evaluation of Cancer's Response.
Tomasz KrzysztofiakMagdalena SuchorzepkaAndrzej TukiendorfPiotr WojcieszekGrażyna Kamińska-WinciorekPublished in: Dermatology and therapy (2023)
Dermoscopy is proven to be easy to perform and an adequate monitoring tool for patients with BCCs undergoing HDR brachytherapy.